Jackson Square Capital, LLC Gilead Sciences, Inc. Transaction History

Jackson Square Capital, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 16, 2024	SELL	$71.58 - $87.29 $9,806 - $11,958	-137 Reduced 0.96%	14,192 $1.04 Million
Q4 2023 Jan 09, 2024	BUY	$73.27 - $83.09 $3,736 - $4,237	51 Added 0.36%	14,329 $1.16 Million
Q3 2023 Oct 25, 2023	BUY	$73.94 - $80.67 $47,173 - $51,467	638 Added 4.68%	14,278 $1.07 Million
Q2 2023 Jul 28, 2023	BUY	$76.01 - $86.7 $15,125 - $17,253	199 Added 1.48%	13,640 $1.05 Million
Q1 2023 Apr 21, 2023	BUY	$77.31 - $88.08 $14,302 - $16,294	185 Added 1.4%	13,441 $1.12 Million
Q4 2022 Jan 23, 2023	BUY	$62.32 - $89.47 $826,113 - $1.19 Million	13,256 New	13,256 $0
Q4 2020 Mar 05, 2021	SELL	$56.65 - $64.55 $48,719 - $55,513	-860 Closed	0 $0
Q4 2019 May 15, 2020	BUY	$61.62 - $67.78 $52,993 - $58,290	860 New	860 $56,000

1,880

1.02B

12M

8.96M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $106B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Jackson Square Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Square Capital, LLC with notifications on news.